Aspen Pharmacare Limited (APNHY)

PNK: APNHY · Real-Time Price · USD

6.76

0.76 (12.67%)

At close: May 02, 2025, 2:31 PM

Aspen Pharmacare Balance Sheet Statement

Financials in ZAR. Fiscal year is July - June.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017
Cash & Equivalents	12.34B	10.91B	6.18B	8.55B	7.09B	8.98B	11.17B	10.7B
Short-Term Investments	n/a	n/a	n/a	9M	6M	2M	-940M	2M
Long-Term Investments	654M	265M	351M	622M	1.15B	1.02B	1.13B	1.6B
Other Long-Term Assets	298M	343M	329M	305M	324M	801M	857M	-100M
Receivables	10.3B	10.09B	8.24B	10.44B	12.89B	12.1B	9.64B	13.2B
Inventory	18B	19.61B	15.76B	13.41B	16.41B	14.65B	14.5B	13.6B
Other Current Assets	3.21B	3.55B	4.04B	78M	17M	52M	3.36B	200M
Total Current Assets	44.09B	44.5B	34.56B	32.7B	36.74B	36.15B	40.22B	38.1B
Property-Plant & Equipment	20.51B	18.9B	16.22B	15.23B	14.83B	12.06B	11.37B	9.8B
Goodwill & Intangibles	71.81B	68.7B	58.66B	59.5B	78.42B	71.12B	78.29B	65.9B
Total Long-Term Assets	95.07B	89.78B	76.81B	76.98B	96.43B	86.16B	92.61B	78.2B
Total Assets	139.16B	134.28B	111.38B	109.68B	133.17B	122.32B	132.84B	116.3B
Account Payables	4.37B	3.97B	3.64B	3.3B	3.37B	3.93B	4.49B	5.18B
Deferred Revenue	n/a	11.17B	7.74B	8.49B	7.99B	7.54B	12.12B	10.4B
Short-Term Debt	11.04B	7.74B	11.54B	24.48B	6.18B	8.26B	11.23B	18.86B
Other Current Liabilities	7B	9.6B	6.54B	5.97B	6.78B	6.95B	10.07B	7.5B
Total Current Liabilities	24.38B	23.15B	23.39B	36.75B	18.08B	20.04B	28.21B	34.8B
Long-Term Debt	24.82B	21.38B	10.36B	n/a	35.58B	39.71B	46.72B	28.9B
Other Long-Term Liabilities	3.19B	353M	4.48B	5.18B	7.05B	6.18B	5.43B	7.4B
Total Long-Term Liabilities	29.91B	24.9B	17.04B	7.31B	45.87B	48.06B	54.53B	38.4B
Total Liabilities	54.29B	48.05B	40.43B	44.06B	63.95B	68.1B	82.74B	73.2B
Total Debt	36.46B	29.28B	22.25B	24.87B	42.32B	47.96B	57.95B	47.8B
Common Stock	2.02B	2.02B	2.02B	2.09B	2.09B	2.09B	1.91B	2.1B
Retained Earnings	60.76B	58.13B	54.34B	50.76B	45.91B	41.25B	37.05B	32.3B
Comprehensive Income	22.45B	26.43B	14.82B	13B	21.4B	11.05B	11.12B	8.9B
Shareholders Equity	84.86B	86.24B	70.94B	65.63B	69.22B	54.21B	50.07B	43.1B
Total Investments	654M	265M	351M	9M	6M	2M	194M	1.6B